For the quarter ended February 2025, Neogen (NEOG) reported revenue of $220.98 million, down 3.4% over the same period last year. EPS came in at $0.10, compared to $0.12 in the year-ago quarter.
The reported revenue represents a surprise of -0.92% over the Zacks Consensus Estimate of $223.03 million. With the consensus EPS estimate being $0.13, the EPS surprise was -23.08%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Animal Safety: $68.25 million compared to the $68.77 million average estimate based on three analysts. The reported number represents a change of -4% year over year.
- Revenues- Food Safety: $152.73 million compared to the $154.26 million average estimate based on three analysts. The reported number represents a change of -3.2% year over year.
- Revenues- Food Safety- Indicator Testing, Culture Media & Other: $77.74 million compared to the $78.53 million average estimate based on two analysts. The reported number represents a change of -4.2% year over year.
- Revenues- Animal Safety- Life Sciences: $1.50 million versus $1.36 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change.
- Revenues- Animal Safety- Veterinary Instruments & Disposables: $15.41 million compared to the $17.93 million average estimate based on two analysts. The reported number represents a change of -14.3% year over year.
- Revenues- Animal Safety- Animal Care & Other: $10.50 million compared to the $10.15 million average estimate based on two analysts. The reported number represents a change of +4.3% year over year.
- Revenues- Food Safety- Natural Toxins & Allergens: $17.60 million compared to the $19.62 million average estimate based on two analysts. The reported number represents a change of -10.9% year over year.
- Revenues- Animal Safety- Genomics Services: $17.01 million versus $6.43 million estimated by two analysts on average.
- Revenues- Food Safety- Genomics Services: $5.70 million versus the two-analyst average estimate of $18.46 million.
- Revenues- Food Safety- Rodent Control, Insect Control & Disinfectants: $11.82 million compared to the $10.72 million average estimate based on two analysts. The reported number represents a change of +16.6% year over year.
- Revenues- Food Safety- Bacterial & General Sanitation: $39.88 million versus $39.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.3% change.
- Revenues- Animal Safety- Rodent Control, Insect Control & Disinfectants: $23.83 million compared to the $21.16 million average estimate based on two analysts. The reported number represents a change of +3.4% year over year.
View all Key Company Metrics for Neogen here>>>
Shares of Neogen have returned -28.8% over the past month versus the Zacks S&P 500 composite's -13.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Neogen Corporation (NEOG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
